Biocon Share Price Target 2024, 2025, 2026, 2027, 2030, 2035, 2040, 2045, 2050

From here you can know whether Biocon’s stock should be bought or sold. Biocon shares future predictions for 2023, 2024, 2025, 2030, 2035, and 2050.

nse: Biocon Share Price Target’s share has increased by +27.00 (10.51%) in the last 1 years and -37.45 (-11.66%) increased in last 5 years.

• Free share for every two held, Biocon Ltd Announce Bonus share in 2024

Biocon Share Price Target 2024, 2025, 2026, 2027, 2028, 2030, 2035, 2040, 2050

Read More

• Rattanindia Power Share Price Target 2023, 2024, 2025, 2030 Complete information

• BHEL Share Price Target 2023, 2024, 2025, 2026, 2027, 2030, 2035, 2040, 2050

• Paramount Cables share: A remarkable journey with 200% returns in 1 year, buy these shares immediately

Biocon Share Price Target 2050

Based on analysis by stock experts, The share price range is set at ₹9000 as the minimum, while after the year, the maximum target price for Biocon shares is expected to be ₹10,000.

Year	1st Target Rs.	2nd Target Rs.
2050	₹9000	₹10,000

Future Prediction of  Biocon Ltd 2023 to 2050

Years	1st Targets (₹)	2nd Targets (₹)
2024	₹294	₹310
2025	₹350	₹360
2026	₹380	₹400
2027	₹550	₹590
2030	₹900	₹1000
2035	₹2000	₹2100
2040	₹3000	₹4000
2045	₹5500	₹7000
2050	₹9000	₹10,000

About Biocon

Visit Biocon Limited’s official website at biocon.com to explore information about this Indian biopharmaceutical company headquartered in Bangalore. Established in 1978 by Kiran Mazumdar-Shaw, Biocon specializes in manufacturing generic active pharmaceutical ingredients distributed across approximately 120 countries, including the United States and Europe.

The company, led by CEO Siddharth Mittal since December 1, 2019, boasts a workforce of 16,545 employees as of 2023 and reported a revenue of 11,550 crores INR (US$1.4 billion) in the same year.

Biocon Limited – Fundamental Analysis

Metric	Value
MARKET CAP	₹34,973.48 Cr.
ENTERPRISE VALUE	₹35,550.88 Cr.
NUMBER OF SHARES	120.06 Cr.
P/E (Price/Earnings)	18.15
P/B (Price/Book)	3.22
FACE VALUE	₹5
DIVIDEND YIELD	0.51%
BOOK VALUE (TTM)	₹90.38
CASH	₹720.30 Cr.
DEBT	₹1,297.70 Cr.
PROMOTER HOLDING	60.64%
EPS (TTM)	₹16.05
SALES GROWTH	14.65%
RETURN ON EQUITY (ROE)	30.29%
RETURN ON CAPITAL EMPLOYED (ROCE)	29.84%
PROFIT GROWTH	3,208.25%

To enhance our comprehension of the market performance, let’s examine the historical outlook of this share in previous years. Nevertheless, investors should exercise caution by considering the associated risks and prevailing market conditions before making any investment decisions.

Last 5 Years’ Sales:

Future of Biocon Share Price 

Risk of Biocon Ltd Share

Over the past three years, the company has demonstrated a modest revenue growth of 0.08%. The tax rate is notably low, standing at 4.13%. Additionally, the company is currently trading at a relatively high EV/EBITDA ratio of 100.29.

Biocon Ltd Share Price Summary

Biocon Ltd 52 Week Low and 52 Week High, Biocon Ltd’s all-time high of 481.95 rs.

Metric	Value
Open	293.20
High	293.20
Low	283.60
Market Cap	33.93 TCr
P/E Ratio	68.08
Dividend Yield	0.53%
52-week High	294.50
52-week Low	191.55

Shareholding Pattern Of Biocon Ltd share

 

Summary	2024
Promoter	60.64%
FII	7.97%
DII	14.08%
Public	17.32%

 

Should You Invest In Biocon Ltd Shares?

Over the last three years, the company has demonstrated robust profit growth, achieving an impressive 86.90%. The firm maintains a healthy interest coverage ratio of 43.69, ensuring a sound ability to meet its interest obligations. With a PEG ratio of 0.01, the company indicates a favorable balance between its stock’s valuation and expected earnings growth.

Furthermore, the company boasts an efficient Cash Conversion Cycle, completing transactions in just 64.56 days. Bolstering its financial health, the current ratio stands at a robust 3.68, underlining a strong liquidity position. Notably, the company enjoys a high promoter holding of 60.64%, signifying confidence in its leadership. Additionally, the company exhibits a significant degree of operating leverage, with average operating leverage of 42.78, indicating its ability to magnify returns as revenue grows.

Conclusion

This article serves as a comprehensive guide to the Biocon Ltd Share Price target. The information and forecasts are derived from our analysis, research, company fundamentals, historical data, experiences, and various technical analyses. The article delves into the share’s prospects and growth potential in detail. Feel free to comment below if you have any further queries. We are more than happy to address all your questions. If you find this information helpful, consider sharing the article with as many people as possible.

Disclaimer:

Dear readers, please be advised that we are not authorized by SEBI (Securities and Exchange Board of India). The information provided on this site is solely for informational and educational purposes and should not be construed as financial advice or stock recommendations. Additionally, share price predictions are intended for reference purposes only and are valid only under positive market conditions.

This study does not consider any uncertainties regarding the company’s future or the current market conditions. While this information is for informational purposes, we disclaim any responsibility for potential financial losses incurred based on the information provided on this site. We aim to offer timely updates about the stock market and financial products to assist you in making informed investment decisions. It is crucial to conduct your research before making any investment decisions.

FAQs